AMGEN INC is 71.0x more valuable than Relay Therapeutics, Inc. by market capitalization ($183.41 B vs $2.58 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | RLAY | AMGN |
|---|---|---|
| Market cap | $2.58 B | $183.41 B |
| US-listed rank | #1918 | #79 |
| Revenue (latest FY) | $15.36M | $36.75B |
| Net income (latest FY) | -$276.48M | $7.71B |
| Net margin | -1800.6% | 21.0% |
| P/E (trailing FY) | - | 23.8 |
| SEC filings | 506 | 1,011 |
AMGEN INC is 71.0x more valuable than Relay Therapeutics, Inc. by market capitalization ($183.41 B vs $2.58 B).
In their latest fiscal years, Relay Therapeutics, Inc. reported $15.36M in revenue while AMGEN INC reported $36.75B.
Full pages: Relay Therapeutics, Inc. and AMGEN INC, or browse the full rankings.